Inovio Pharma buy Piper Sandler
Start price
14.11.25
/
50%
€0.53
Target price
14.11.26
-
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 14.11.26. The prediction end date can be changed by Piper_Sandler at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Inovio Pharma | - | - |
| iShares Core DAX® | 0,88 % | 5,63 % |
| iShares Nasdaq 100 | 2,39 % | 1,57 % |
| iShares Nikkei 225® | 4,27 % | 2,52 % |
| iShares S&P 500 | 1,17 % | 2,55 % |
Comments by Piper_Sandler for this prediction
In the thread Inovio Pharma diskutieren
Inovio Pharmaceuticals (NASDAQ:INO) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Ratings data for INO provided by MarketBeat